• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

用药史对精神分裂症中潜伏期听觉诱发电位的影响。

Effects of medication history on midlatency auditory evoked responses in schizophrenia.

作者信息

Erwin R J, Shtasel D, Gur R E

机构信息

Department of Psychiatry, University of Pennsylvania, Philadelphia 19104.

出版信息

Schizophr Res. 1994 Feb;11(3):251-8. doi: 10.1016/0920-9964(94)90019-1.

DOI:10.1016/0920-9964(94)90019-1
PMID:7910754
Abstract

The recovery cycle of the P1 component of the auditory evoked potential (50-70 ms latency) has been reported as abnormal in both unmedicated and medicated patients with schizophrenia when a paired stimuli protocol is used to examine recovery. However, findings have been mixed when a stimulus train protocol is used. This study examined the effects of medication history on P1 abnormalities in schizophrenia assessed by a stimulus train protocol. Auditory evoked potentials were recorded from 14 normal controls, 14 neuroleptic naive patients with schizophrenia and 14 previously medicated patients in response to binaural clicks presented at three stimulus rates: 1/s, 5/s and 10/s. Neuroleptic naive patients showed a smaller P1 at the baseline rate (1/s) and greater recovery (less amplitude suppression) at faster rates than did normal controls or previously medicated patients. Additional analyses suggested that this latter effect was not due to smaller baseline P1 amplitudes. Greater recovery in neuroleptic naive patients was not associated with clinical symptomatology contrary to previous findings of the authors for a mixed sample of neuroleptic naive and previously medicated patients. Medication status appears to account for some of the variability in P1 abnormalities in schizophrenia although identification of the underlying mechanism responsible requires further study.

摘要

当使用配对刺激方案来检测恢复情况时,据报道,未用药和用药的精神分裂症患者的听觉诱发电位P1成分(潜伏期为50 - 70毫秒)的恢复周期均异常。然而,当使用刺激序列方案时,研究结果则喜忧参半。本研究通过刺激序列方案,考察了用药史对精神分裂症患者P1异常的影响。对14名正常对照者、14名未使用过抗精神病药物的精神分裂症患者以及14名曾使用过药物的患者记录听觉诱发电位,刺激为双耳短声,呈现三种刺激频率:1次/秒、5次/秒和10次/秒。与正常对照者或曾使用过药物的患者相比,未使用过抗精神病药物的患者在基线频率(1次/秒)时P1波幅较小,而在较快频率时恢复程度更大(波幅抑制较小)。进一步分析表明,后一种效应并非由于基线P1波幅较小所致。与作者之前对未使用过抗精神病药物和曾使用过药物的混合样本的研究结果相反,未使用过抗精神病药物的患者恢复程度更高与临床症状无关。用药状态似乎可以解释精神分裂症患者P1异常的部分变异性,尽管确定其潜在机制还需要进一步研究。

相似文献

1
Effects of medication history on midlatency auditory evoked responses in schizophrenia.用药史对精神分裂症中潜伏期听觉诱发电位的影响。
Schizophr Res. 1994 Feb;11(3):251-8. doi: 10.1016/0920-9964(94)90019-1.
2
Midlatency auditory evoked responses in schizophrenia.精神分裂症中的中潜伏期听觉诱发电位
Biol Psychiatry. 1991 Sep 1;30(5):430-42. doi: 10.1016/0006-3223(91)90304-5.
3
Auditory event-related potentials and electrodermal activity in medicated and unmedicated schizophrenics.
Biol Psychiatry. 1991 Mar 15;29(6):585-99. doi: 10.1016/0006-3223(91)90094-3.
4
Auditory event-related potentials, auditory digit span, and clinical symptoms in chronic schizophrenic men on neuroleptic medication.服用抗精神病药物的慢性精神分裂症男性患者的听觉事件相关电位、听觉数字广度及临床症状
Biol Psychiatry. 1996 Jul 1;40(1):19-27. doi: 10.1016/0006-3223(95)00351-7.
5
The P50 component of the auditory evoked potential and subtypes of schizophrenia.
Psychiatry Res. 1993 Jun;47(3):243-54. doi: 10.1016/0165-1781(93)90082-r.
6
Dopaminergic modulation of the P50 auditory-evoked potential in a computer model of the CA3 region of the hippocampus: its relationship to sensory gating in schizophrenia.海马体CA3区计算机模型中P50听觉诱发电位的多巴胺能调节:其与精神分裂症感觉门控的关系。
Biol Cybern. 2003 Apr;88(4):265-75. doi: 10.1007/s00422-002-0372-8.
7
Delayed peak latency of the mismatch negativity in schizophrenics and alcoholics.精神分裂症患者和酗酒者失匹配负波的峰潜伏期延迟。
Biol Psychiatry. 1995 May 15;37(10):754-7. doi: 10.1016/0006-3223(94)00309-Q.
8
Event-related potential abnormalities correlate with structural brain alterations and clinical features in patients with chronic schizophrenia.慢性精神分裂症患者的事件相关电位异常与脑结构改变及临床特征相关。
Schizophr Res. 1994 Feb;11(3):259-71. doi: 10.1016/0920-9964(94)90020-5.
9
N2 and P3 components of event-related potential in first-episode schizophrenic patients: scalp topography, medication, and latency effects.首发精神分裂症患者事件相关电位的N2和P3成分:头皮地形图、药物治疗及潜伏期效应
Psychiatry Res. 2002 Aug 30;111(2-3):167-79. doi: 10.1016/s0165-1781(02)00133-6.
10
Neurophysiological evidence for a defect in inhibitory pathways in schizophrenia: comparison of medicated and drug-free patients.精神分裂症抑制性通路缺陷的神经生理学证据:服药患者与未服药患者的比较
Biol Psychiatry. 1983 May;18(5):537-51.

引用本文的文献

1
Deficit Effect Sizes and Correlations of Auditory Event-Related Potentials at First Hospitalization in the Schizophrenia Spectrum.精神分裂症谱系患者首次住院时听觉事件相关电位的缺陷效应量与相关系数。
Clin EEG Neurosci. 2020 Jul;51(4):198-206. doi: 10.1177/1550059419868115. Epub 2019 Aug 7.
2
A putative electrophysiological biomarker of auditory sensory memory encoding is sensitive to pharmacological alterations of excitatory/inhibitory balance in male macaque monkeys.听觉感觉记忆编码的假定电生理生物标志物对雄性猕猴兴奋性/抑制性平衡的药物改变敏感。
J Psychiatry Neurosci. 2018 May;43(3):182-193. doi: 10.1503/jpn.170093.
3
Loudness- and time-dependence of auditory evoked potentials is blunted by the NMDA channel blocker MK-801.
NMDA通道阻滞剂MK-801可减弱听觉诱发电位的响度和时间依赖性。
Psychiatry Res. 2017 Oct;256:202-206. doi: 10.1016/j.psychres.2017.06.047. Epub 2017 Jun 15.
4
Upregulation of adenosine A2A receptors induced by atypical antipsychotics and its correlation with sensory gating in schizophrenia patients.非典型抗精神病药物诱导的腺苷 A2A 受体上调及其与精神分裂症患者感觉门控的相关性。
Psychiatry Res. 2012 Dec 30;200(2-3):126-32. doi: 10.1016/j.psychres.2012.04.021. Epub 2012 Jun 16.
5
Neurophysiological and neurochemical animal models of schizophrenia: focus on glutamate.精神分裂症的神经生理和神经化学动物模型:聚焦于谷氨酸。
Behav Brain Res. 2009 Dec 7;204(2):352-62. doi: 10.1016/j.bbr.2009.05.005. Epub 2009 May 9.
6
The auditory P50 component to onset and offset of sound.声音起始和结束时的听觉P50成分。
Clin Neurophysiol. 2008 Feb;119(2):376-87. doi: 10.1016/j.clinph.2007.10.016. Epub 2007 Dec 4.
7
Auditory processing in schizophrenia during the middle latency period (10-50 ms): high-density electrical mapping and source analysis reveal subcortical antecedents to early cortical deficits.精神分裂症患者在中潜伏期(10 - 50毫秒)的听觉处理:高密度脑电图描记术和源分析揭示早期皮质缺陷的皮质下先兆。
J Psychiatry Neurosci. 2007 Sep;32(5):339-53.
8
Noradrenergic antagonism of the P13 and N40 components of the rat auditory evoked potential.大鼠听觉诱发电位P13和N40成分的去甲肾上腺素能拮抗作用。
Psychopharmacology (Berl). 2007 Jan;190(1):117-25. doi: 10.1007/s00213-006-0608-8. Epub 2006 Nov 10.